Literature DB >> 8431206

Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis.

L S Lohmander1, L A Hoerrner, M W Lark.   

Abstract

OBJECTIVE: To determine the concentrations of human stromelysin-1, collagenase, tissue inhibitor of metalloproteinases (TIMP), and proteoglycan fragments in knee synovial fluid in patients with injury to the meniscus or anterior cruciate ligament, posttraumatic osteoarthritis, primary osteoarthritis, or pyrophosphate arthritis.
METHODS: Synovial fluid samples were collected from patients with knee disease diagnosed arthroscopically and radiologically. Concentrations of stromelysin-1, collagenase, and TIMP-1 were determined by sandwich immunoassay, using monoclonal and polyclonal antibodies. Fragments of cartilage proteoglycan containing the chondroitin sulfate-binding region were determined by immunoassay with a polyclonal antibody.
RESULTS: Average concentrations of metalloproteinases, TIMP, and proteoglycan fragments in joint fluid were significantly elevated in patients from all disease groups as compared with volunteers with healthy knees (reference group). Stromelysin concentrations in disease groups averaged 15-45 times that of the reference group. The molar ratios between stromelysin and collagenase varied between 10 and 150. The molar ratio between total stromelysin and free TIMP was 0.5 in the reference group and between 1.6 and 5.3 in the disease groups.
CONCLUSION: Stromelysin concentration in joint fluid is a parameter that distinguishes diseased joints from healthy joints, with a sensitivity of 84% and a specificity of 90%. The high concentrations of metalloproteinase relative to TIMP in joint fluid from patients with the conditions studied may be associated with cartilage matrix degradation in these arthritides.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431206     DOI: 10.1002/art.1780360207

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  58 in total

Review 1.  The role of crystals in articular tissue degeneration.

Authors:  H S Cheung
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

2.  Why Do Osteochondral Allografts Survive? Comparative Analysis of Cartilage Biochemical Properties Unveils a Molecular Basis for Durability.

Authors:  Lei Ding; Biagio Zampogna; Sebastiano Vasta; Kee Woong Jang; Francesca De Caro; James A Martin; Annunziato Amendola
Journal:  Am J Sports Med       Date:  2015-08-26       Impact factor: 6.202

3.  Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.

Authors:  M W Lark; E K Bayne; J Flanagan; C F Harper; L A Hoerrner; N I Hutchinson; I I Singer; S A Donatelli; J R Weidner; H R Williams; R A Mumford; L S Lohmander
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

Review 4.  Nonsteroidal anti-inflammatory drugs and chondroprotection. A review of the evidence.

Authors:  P Ghosh
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

5.  Arthritis diagnosis based upon the near-infrared spectrum of synovial fluid.

Authors:  R A Shaw; S Kotowich; H H Eysel; M Jackson; G T Thomson; H H Mantsch
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

6.  Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.

Authors:  N Di Girolamo; A Lloyd; P McCluskey; M Filipic; D Wakefield
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

7.  Co-culture of mechanically injured cartilage with joint capsule tissue alters chondrocyte expression patterns and increases ADAMTS5 production.

Authors:  J H Lee; J B Fitzgerald; M A DiMicco; D M Cheng; C R Flannery; J D Sandy; A H Plaas; A J Grodzinsky
Journal:  Arch Biochem Biophys       Date:  2009-07-14       Impact factor: 4.013

8.  Effect of depletion of glycosaminoglycans and non-collagenous proteins on interstitial hydraulic permeability in rabbit synovium.

Authors:  D Scott; P J Coleman; A Abiona; D E Ashhurst; R M Mason; J R Levick
Journal:  J Physiol       Date:  1998-09-01       Impact factor: 5.182

9.  Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study.

Authors:  Staffan Larsson; L Stefan Lohmander; André Struglics
Journal:  Arthritis Res Ther       Date:  2009-06-22       Impact factor: 5.156

10.  Tumor necrosis factor alpha-dependent aggrecan cleavage and release of glycosaminoglycans in the meniscus is mediated by nitrous oxide-independent aggrecanase activity in vitro.

Authors:  Henning Voigt; Angelika K Lemke; Rolf Mentlein; Michael Schünke; Bodo Kurz
Journal:  Arthritis Res Ther       Date:  2009-09-24       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.